A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer

PURPOSE: Neoadjuvant chemotherapy (NC) is yet to be established as the definitive treatment regimen for locally advanced breast cancer (LABC). The aim of this study was to determine the efficacy and toxicity of NC with epirubicin and paclitaxel. METHODS: Between March 2007 and January 2009, 50 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinsun, Kim, Jeryong, Chang, Eilsung, Choi, Woonjung, Lee, Kwangman, Yoon, Hyunjo, Jung, Sunghoo, Park, Minho, Yoon, Junghan, Kim, Sungyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278053/
https://www.ncbi.nlm.nih.gov/pubmed/25548582
http://dx.doi.org/10.4048/jbc.2014.17.4.344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278053/
https://www.ncbi.nlm.nih.gov/pubmed/25548582
http://dx.doi.org/10.4048/jbc.2014.17.4.344

Ejemplares similares